Latest Views & News

Advanced Oncotherapy – Flip-flop Delay To Fundraise!

By Nigel Somerville, the Deputy Sheriff of AIM | Friday 22 April 2022

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

On 12th April 2022 AIM-listed Advanced Oncotherapy (AVO) announced an equity fundraise of £1.735 million at 25p a pop – a premium to market, but only at par price. We were told that the fundraise has been conducted through a direct subscription with the Company (the "Subscription") for a total of 6,940,000 new ordinary shares. So the money was in the bank, right? Wrong….

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



The ongoing saga of woe at Saga



The ShareProphets Sunday Pub Quiz #160



Gyrations at Victoria Carpets



GOTCHA: admits it is fucked



Stuff happens but we are not stuffed



The ShareProphets Sunday Pub Quiz #159



Challenges continue at Ocado



Iconic Labs – back from the dead?



Pure Gold – Pure Ramping!

Sunday »


The ShareProphets Sunday Pub Quiz #158



Buy Orcadian Energy